| URL | https://www.pharmoutsourcing.com/1315-News/628548- |
| Source | Pharmaceutical Outsourcing |
| Date Published | 10/02/2026 |
| Company/Division name | SK pharmteco |
| Parent company | SK pharmteco |
| Type of work | Manufacturing |
| Reshoring category: | Reshoring |
| Total number of jobs (added or to be added): | 100 |
| Year reshoring announced: | 2026 |
| Year reshoring implemented or to be implemented: | 2031 |
| Capital investment ($): | 200 |
| If relevant, work nearshored to: | - |
| Industry(ies): | Chemicals |
| Product(s) reshored | pharma |
| What domestic positive factors made reshoring more attractive? | Government Incentives, Higher productivity, Proximity to customers/market |